- Though it beat FQ3 estimates, Synopsys (NASDAQ:SNPS) is guiding for FQ4 revenue of $537M-$547M and EPS of $0.59-$0.61, mostly below a consensus of $547M and $0.63.
- FQ3 time-based license revenue +11% Y/Y to $431.2M; up-front license revenue -21% to $31.6M; maintenance/service revenue +6% to $59M. GAAP R&D spend +10% to $182.8M; sales/marketing +7% to $112.3M.
- Synopsys says it's seeing "encouraging results" from recently-acquired software quality/testing tool vendor Coverity.
- Shares -0.8% AH. FQ3 results, PR.
From other sites
at CNBC.com (Dec 19, 2014)
at CNBC.com (Dec 1, 2014)
at CNBC.com (Aug 20, 2014)
at CNBC.com (May 21, 2014)
at CNBC.com (Dec 4, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs